Procalcitonin is a marker of gram-negative bacteremia in patients with sepsis

American Journal of the Medical Sciences

Volumn 349, Issue 6, 2015, Pages 499-504

  Guo, Shun Yuan ^a   Zhou, Yin ^a   Hu, Qing Feng ^a   Yao, Jiong ^a   Wang, Hong ^a  

^a ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Bacteremia; C reactive protein; Procalcitonin; Sepsis

Indexed keywords

PROCALCITONIN; BIOLOGICAL MARKER; CALCITONIN; PROTEIN PRECURSOR;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD CULTURE; BLOODSTREAM INFECTION; CANDIDA; DEPENDENT VARIABLE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE SEPSIS; GRAM POSITIVE BACTERIUM; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEPSIS; THROMBOCYTE COUNT; BACTEREMIA; BLOOD; GRAM NEGATIVE INFECTION; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BACTEREMIA; BIOMARKERS; CALCITONIN; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROTEIN PRECURSORS; RETROSPECTIVE STUDIES;

EID: 84930432677     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0000000000000477     Document Type: Article

References (22)

1. Vincent JL, Marshall J, Silva E, et al; EPIC II Group of Investigators. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009;302:2323-9.
2. Dillinger RP, Levy MM, Rhodes A, et al; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guideline for management of severe sepsis and sepsis shock, 2012. Crit Care Med 2013;41:580-637.
3. Vincent JL, Sakr Y, Sprung CL, et al; Sepsis Occurrence in Acutely Ill Patients Investigators. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2009;34:344-53.
4. Bone RC, Fisher CJ Jr, Clemmer TP, et al. Sepsis syndrome: a valid clinical entity. Methylprednisolone severe sepsis study group. Crit Care Med 1989;17:389-93.
5. Cunha BA. Antibiotic selection in CCU. In: Cunha BA, editor. Infectious Disease in Critical Care Medicine, 2nd ed. New York: Informa Healthcare; 2007.
6. Ambrose PG, Owens RC, Quintiliani R, et al. Antibiotic use in the critical care unit. Crit Care Clin 1998;8:283-308.
7. Thomas PL, Drusano G, Zasawski E, et al. Vancomycin exposure in patients with methicillin-resistant staphylococcus aureus bloodstream how much is enough? Clin Infect Dis 2014;59:666-75.
8. Christ-Grain M, Muller B. Procalcitonin in bacterial infection-hype, hope, more or less? Swiss Med Wkly 2005;135:451-60.
9. Wacker C, Prkno A, Brunkhorst FM, et al. Procalcitonin as a diagnostic marker for sepsis: a system review and meta-Analysis. Lancet Infect Dis 2013;12:70323-7.
10. Balcl C, Sungurtekin H, Gurses E, et al. Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Crit Care 2003;23:85.
11. Tang BM, Eslick GD, Graig JC, et al. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and metaanalysis. Lancet Infect Dis 2007;7:210-7.
12. Konrad R, Michael B, Niels CR, et al. New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev 2012;25: 609-34.
13. Bateman BT, Schmidt U, Berman MF, et al. Temporal trends in the epidemiology of severe postoperative sepsis after elective surgery: a large, nationwide sample. Anesthesiology 2010;112:917-25.
14. Brodska H, Malickova K, Adamkova V, et al. Significantly higher procalcitonin levels could differentiate gram-negative sepsis from Gram-positive and fungal sepsis. Clin Exp Med 2013;3:165-70.
15. Gao H, Evans TW, Finney SJ. Bench-to bedside review: sepsis, severe sepsis and sepsis shock-does the nature of the infecting organism matter? Crit Care 2008;12:213-21.
16. Marshall JC, Foster D, Vincent JL, et al; MEDIC Study. Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis 2004;190:527-34.
17. Cortegiani A, Russotto V, Montalto F, et al. Procalcitonin as a marker of candida species detection by blood culture and polymerase chain reaction in septic patients. BMC Anesthesiol 2014;14:1-9.
18. Boomer JS, To K, Chang KC, et al. Immunosuppression in patients who died of sepsis and multiple organ failure. JAMA 2011;306:2594-603.
19. Arai T, Kumasaka K, Nagata K, et al. Prediction of blood culture results by measuring procalcitonin levels and other inflammatory biomarkers. Am J Emerg Med 2014;32:330-3.
20. Charles PE, Ladoir S, Aho S, et al. Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteria. BMC Infect Dis 2008;8:38-42.
21. Chang SS, Hsieh WH, Liu TS, et al. Multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis-a system review and meta-Analysis. PLoS One 2013;8:E62323.
22. Diekes C, Ehrenstein B, Siebig S, et al. Clinical impact of commercially available multiple PCR system for rapid detection of pathogens in patients with presumed sepsis. BMC Infect Dis 2009;9:126-34.